CastleArk Alternatives’s HCA Healthcare HCA Stock Holding History

CastleArk Alternatives’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-130,885	Closed	-$31.8M	–	131
2021 Q3	$31.8M	Buy	+130,885	New	+$32M	1.21%	23

Other funds holding HCA

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CastleArk Alternatives's HCA Position: Q4 2021 in Review

CastleArk Alternatives sold out of HCA Healthcare (HCA) in Q4 2021, closing a stake of 130,885 shares — an estimated $31.8M sold.

CastleArk Alternatives first reported a position in HCA in Q3 2021 and held it in 1 quarter. The position peaked at $31.8M in Q3 2021. 947 funds tracked by Wall St. Rank hold HCA as of Q4 2021.

CastleArk Alternatives reported no remaining HCA Healthcare position as of Q4 2021 after selling out during the quarter.
CastleArk Alternatives sold 130,885 HCA Healthcare shares in Q4 2021, an estimated $31.8M.
CastleArk Alternatives first reported a position in HCA Healthcare in Q3 2021 and held it in 1 quarter.
CastleArk Alternatives's HCA Healthcare position peaked at $31.8M in Q3 2021.
947 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2021.

Based on CastleArk Alternatives's 13F filing for Q4 2021, filed 18 Feb 2022.